Come True Biomedical Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 28.687 million compared to TWD 21.273 million a year ago. Operating loss was TWD 4.755 million compared to TWD 16.656 million a year ago. Net loss was TWD 3.111 million compared to TWD 9.106 million a year ago. Basic loss per share was TWD 0.1 compared to TWD 0.29 a year ago. For the nine months, sales was TWD 74.284 million compared to TWD 74.770 million a year ago. Operating loss was TWD 33.168 million compared to TWD 39.195 million a year ago. Net loss was TWD 22.866 million compared to TWD 49.511 million a year ago. Basic loss per share was TWD 0.72 compared to TWD 1.56 a year ago.